Eva Riveira Muñoz
Eva Riveira Muñoz (b. 1977) obtained a degree in Biology from the University of Santiago de Compostela (USC). She then moved to Brussels (Belgium) to pursue a PhD degree, which she obtained from the Université Catholique de Louvain in 2007. Returning to Spain, she spent three years as a post-doc at the Centre for Genomic Regulation in Barcelona. In 2012 she moved to IrsiCaixa, where she is now working as a post-doc at the Virus-Host Interactions group, led by Ester Ballana.
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.
Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
International Conference on Antiviral Research.